NYSE:ALLEAllegion Stock Price, Forecast & News

Allegion's stock was trading at $114.78 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ALLE stock has decreased by 12.8% and is now trading at $100.11.
View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last year. There are currently 1 sell rating and 7 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Allegion.

Allegion is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Allegion.

Allegion PLC (NYSE:ALLE) announced its quarterly earnings data on Thursday, July, 23rd. The scientific and technical instruments company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.13. The scientific and technical instruments company earned $589.50 million during the quarter, compared to analyst estimates of $605.87 million. Allegion had a return on equity of 64.29% and a net margin of 10.48%. The firm's revenue was down 19.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.26 earnings per share.
View Allegion's earnings history.

Allegion announced a quarterly dividend on Wednesday, April 8th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.32 per share on Tuesday, June 30th. This represents a $1.28 annualized dividend and a yield of 1.28%. The ex-dividend date is Monday, June 15th.
View Allegion's dividend history.

Allegion announced that its Board of Directors has authorized a stock buyback program on Thursday, February 6th 2020, which allows the company to buyback $800,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 6.5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board believes its stock is undervalued.

Allegion updated its FY20 earnings guidance on Thursday, July, 23rd. The company provided earnings per share guidance of $4.15-4.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.13. The company issued revenue guidance of down 9-10% yr/yr to $2.57-2.60 billion, compared to the consensus revenue estimate of $2.64 billion.

8 Wall Street analysts have issued 12 month target prices for Allegion's shares. Their forecasts range from $97.00 to $140.00. On average, they expect Allegion's stock price to reach $106.57 in the next twelve months. This suggests a possible upside of 6.5% from the stock's current price.
View analysts' price targets for Allegion.

Media headlines about ALLE stock have been trending very negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Allegion earned a daily sentiment score of -3.4 on InfoTrie's scale. They also gave news stories about the scientific and technical instruments company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about Allegion.

Allegion saw a decrease in short interest in July. As of July 31st, there was short interest totaling 3,610,000 shares, a decrease of 15.9% from the July 15th total of 4,290,000 shares. Based on an average daily trading volume, of 735,900 shares, the short-interest ratio is currently 4.9 days. Approximately 3.9% of the shares of the stock are sold short.
View Allegion's Short Interest.

Some companies that are related to Allegion include FANUC LTD JAPAN/ADR (FANUY), Cintas (CTAS), Johnson Controls International (JCI), Mitsui & Co Ltd (MITSY), Rockwell Automation (ROK), Parker-Hannifin (PH), Stanley Black & Decker (SWK), Ball (BLL), SANDVIK AB/ADR (SDVKY), ASSA ABLOY AB/S (ASAZY), Ferguson (FERGY), Techtronic Industries (TTNDY), Komatsu (KMTUY), W W Grainger (GWW) and Kubota (KUBTY).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include AbbVie (ABBV), General Electric (GE), Pfizer (PFE), Walmart (WMT), Abbott Laboratories (ABT), AT&T (T), Citigroup (C), Nucor (NUE), UnitedHealth Group (UNH) and Walt Disney (DIS).

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion's stock is owned by many different institutional and retail investors. Top institutional shareholders include AKO Capital LLP (1.69%), Bessemer Group Inc. (1.10%), Intermede Investment Partners Ltd (0.90%), Russell Investments Group Ltd. (0.80%), Robeco Institutional Asset Management B.V. (0.68%) and Ardevora Asset Management LLP (0.46%). Company insiders that own Allegion stock include Chris E Muhlenkamp, David D Petratis, Douglas P Ranck, Jeffrey M Wood, Jeffrey N Braun, Patrick S Shannon, Timothy P Eckersley and Tracy L Kemp.
View institutional ownership trends for Allegion.

ALLE stock was sold by a variety of institutional investors in the last quarter, including AKO Capital LLP, Bessemer Group Inc., First Trust Advisors LP, Fifth Third Bancorp, Russell Investments Group Ltd., WINTON GROUP Ltd, Picton Mahoney Asset Management, and Oregon Public Employees Retirement Fund. Company insiders that have sold Allegion company stock in the last year include David D Petratis, Douglas P Ranck, Patrick S Shannon, Timothy P Eckersley, and Tracy L Kemp.
View insider buying and selling activity for Allegion.

ALLE stock was acquired by a variety of institutional investors in the last quarter, including CIBC Asset Management Inc, James Hambro & Partners, Victory Capital Management Inc., Andra AP fonden, M&T Bank Corp, Ardevora Asset Management LLP, Vident Investment Advisory LLC, and Intermede Investment Partners Ltd.
View insider buying and selling activity for Allegion.

Shares of ALLE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALLE stock can currently be purchased for approximately $100.11.

Allegion has a market capitalization of $9.23 billion and generates $2.85 billion in revenue each year. The scientific and technical instruments company earns $401.80 million in net income (profit) each year or $4.89 on an earnings per share basis. Allegion employs 11,000 workers across the globe.

The official website for Allegion is www.allegion.com.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The scientific and technical instruments company can be reached via phone at 353-1254-6200 or via email at [email protected]